CIK 0000025743
- Non-accelerated filer
- Smaller reporting company
TherapeuticsMD, Inc.
Sign in to watch- Ticker
- TXMD
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NV
- Entity type
- Operating
- EIN
- 870233535
- Phone
- +1 561-961-1900
- Business address
- 951 YAMATO ROAD, SUITE 220, BOCA RATON, FL, 33431
- Former names
- AMHN, Inc., CROFF ENTERPRISES INC, CROFF OIL CO
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-02-03 | Krassan Mitchell Chief Strategy Officer | Exercise or conversion · Non-Qualified Stock Option (right to buy) | −105,703 | 0 | ||
| 2020-02-03 | Krassan Mitchell Chief Strategy Officer | Exercise or conversion · Non-Qualified Stock Option (right to buy) | −194,297 | 489,658 | ||
| 2019-10-25 | Milligan John C.K. IV President/Secretary | Purchase | +72,000 | $2.75 | $198K | 1,544,419 |
| 2019-10-25 | Milligan John C.K. IV President/Secretary | Purchase | +72,000 | $2.75 | $198K | 1,544,419 |
| 2019-10-25 | Bernick Brian Director | Purchase | +36,000 | $2.75 | $99K | 98,000 |
| 2019-10-25 | Finizio Robert G CEO | Purchase | +72,000 | $2.75 | $198K | 18,325,964 |
| 2019-08-28 | Donegan Michael C Vice President Finance | Grant or award · Non-Qualified Stock Option (right to buy) | +120,000 | 120,000 | ||
| 2019-08-28 | Krassan Mitchell Chief Strategy Officer | Grant or award · Non-Qualified Stock Option (right to buy) | +300,000 | 300,000 | ||
| 2019-08-28 | Milligan John C.K. IV President/Secretary | Grant or award · Non-Qualified Stock Option (right to buy) | +400,000 | 400,000 | ||
| 2019-08-28 | Bernick Brian Director | Grant or award · Non-Qualified Stock Option (right to buy) | +300,000 | 300,000 | ||
| 2019-08-28 | Finizio Robert G CEO | Grant or award · Non-Qualified Stock Option (right to buy) | +1 | 1 | ||
| 2019-08-28 | Cartwright Daniel A Chief Financial Officer | Grant or award · Non-Qualified Stock Option (right to buy) | +220,000 | 220,000 | ||
| 2019-08-23 | Russell Angus C. Director | Purchase | +10,000 | $2.77 | $28K | 93,500 |
| 2019-08-20 | Finizio Robert G CEO | Purchase | +35,000 | $2.74 | $96K | 18,253,964 |
| 2019-08-16 | Milligan John C.K. IV President/Secretary | Purchase | +10,000 | $2.93 | $29K | 3,582,373 |
| 2019-08-15 | Russell Angus C. Director | Purchase | +10,000 | $2.99 | $30K | 83,500 |
| 2019-08-14 | Russell Angus C. Director | Purchase | +25,000 | $2.76 | $69K | 73,500 |
| 2019-08-12 | Barlow Jane F Director | Purchase | +3,144 | $3.18 | $10K | 3,144 |
| 2019-08-12 | Milligan John C.K. IV President/Secretary | Purchase | +15,000 | $3.16 | $47K | 3,572,373 |
| 2019-08-09 | Thompson Tommy G Director | Purchase | +5,000 | $3.04 | $15K | 690,900 |
Page 14 of 24 · 463 trades